Recent News

By Category: Biotechnology

Fact Sheet: East Asia Summit

(White House.gov Press Office) At the East Asia Summit (EAS) held on November 19 in Bali, Indonesia, President Obama and other Asia-Pacific leaders discussed the importance of cooperation on the region’s most pressing political and security challenges, including maritime security, non-proliferation, and disaster response. President Obama’s participation in the EAS was the first by a Read More »

November 22, 2011
| Filed under North America, Biological Weapons, Biotechnology, International, and Policy & Initiatives
Share

Darpa: Do Away With Antibiotics, Then Destroy All Pathogens

(Wired – Danger Room) Last year, federal officials warned that Americans were on the verge of “a post-antibiotic era.” And that’s exactly what the Pentagon’s far-out research agency is after. As long as they’ve got a replacement at the ready, of course. In the military’s latest round of small business solicitations, Darpa is making a Read More »

November 21, 2011
| Filed under North America, Biotechnology, Countermeasures, Policy & Initiatives, Public Health, and Research
Share

ELISA training by FAO

(Pakistan Observer) Chancellor of the US Embassy in Pakistan, Islamabad assured maximum support of US Government for improving capacity of livestock sector of Pakistan in terms of diagnosis and control of animal disease including Foot and Mouth Disease (FMD). …

November 18, 2011
| Filed under South Asia, Agriculture, Biosafety, Biotechnology, International, Policy & Initiatives, and Public Health
Share

Emergent BioSolutions Initiates Pivotal Clinical Trial Evaluating a Three-Dose BioThrax…

(Press release) EBS today announced the initiation of a pivotal immunogenicity and safety study to evaluate a three-dose vaccination schedule of BioThrax(R) (Anthrax Vaccine Adsorbed) for administration to individuals exposed to anthrax. Through this pivotal, licensure-enabling clinical study, the company seeks to obtain a post-exposure prophylaxis (PEP) indication for BioThrax. Approval of the PEP indication Read More »

November 18, 2011
| Filed under North America, Biotechnology, Countermeasures, Public Health, and Research
Share

PharmAthene to Present at the 2011 Chemical and Biological Defense Science and …

(Sacramento Bee) PharmAthene, Inc. announced today that data from its rPA anthrax vaccine and chemical nerve agent bioscavenger programs will be presented at the 2011 Chemical and Biological Defense Science and Technology …